Literature DB >> 19302499

Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS.

Karin S Coyne1, Steven A Kaplan, Christopher R Chapple, Chris C Sexton, Zoe S Kopp, Elizabeth N Bush, Lalitha P Aiyer.   

Abstract

OBJECTIVE: To explore the risk factors and comorbid conditions associated with subgroups of lower urinary tract symptoms (LUTS) in men and women aged > or =40 years in three countries, using data from the EpiLUTS study, as LUTS are common amongst men and women and increase in prevalence with age. SUBJECTS AND METHODS: This cross-sectional, population-representative survey was conducted via the Internet in the USA, the UK and Sweden. Participants were asked to rate how often they experienced individual LUTS during the past 4 weeks on a 5-point Likert scale. Eight LUTS subgroups were created. Descriptive statistics and logistic regressions within each LUTS subgroup were used to assess the data.
RESULTS: The survey response rate was 59%. The final sample was 30,000 (men and women). The voiding + storage + postmicturition (VSPM) group reported the highest rates of comorbid conditions for both men and women, and the fewest were reported in the no/minimal LUTS and the postmicturition-only groups. Increasing age was associated with increasing LUTS in men, but not in women. Comorbid conditions significantly associated with the VSPM group were arthritis, asthma, chronic anxiety, depression, diabetes (men only), heart disease, irritable bowel syndrome, neurological conditions, recurrent urinary tract infection, and sleep disorders. Risk factors, such as body mass index, exercise level and smoking, played less of a role, except for childhood nocturnal enuresis, which was significantly associated with most LUTS subgroups.
CONCLUSION: In this large population study, many comorbid conditions and risk factors were significantly associated with LUTS among both men and women. Further longitudinal investigations of the associations noted here would help physicians to understand the pathophysiology of LUTS and comorbid conditions, and provide clinical guidelines for patient management of comorbid conditions sharing common pathophysiological pathways.

Entities:  

Mesh:

Year:  2009        PMID: 19302499     DOI: 10.1111/j.1464-410X.2009.08438.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  51 in total

1.  Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Authors:  Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay
Journal:  Eur J Clin Pharmacol       Date:  2011-12-04       Impact factor: 2.953

Review 2.  Translational Research and Functional Changes in Voiding Function in Older Adults.

Authors:  Florenta Aura Kullmann; Lori Ann Birder; Karl-Erik Andersson
Journal:  Clin Geriatr Med       Date:  2015-07-23       Impact factor: 3.076

Review 3.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

4.  The Prevention of Lower Urinary Tract Symptoms (PLUS) in girls and women: Developing a conceptual framework for a prevention research agenda.

Authors:  Sonya S Brady; Tamara G Bavendam; Amanda Berry; Cynthia S Fok; Sheila Gahagan; Patricia S Goode; Cecilia T Hardacker; Jeni Hebert-Beirne; Cora E Lewis; Jessica B Lewis; Lisa Kane Low; Jerry L Lowder; Mary H Palmer; Jean F Wyman; Emily S Lukacz
Journal:  Neurourol Urodyn       Date:  2018-08-22       Impact factor: 2.696

5.  Testosterone decreases urinary bladder smooth muscle excitability via novel signaling mechanism involving direct activation of the BK channels.

Authors:  Kiril L Hristov; Shankar P Parajuli; Aaron Provence; Georgi V Petkov
Journal:  Am J Physiol Renal Physiol       Date:  2016-09-07

6.  Lower urinary tract symptoms in older Chinese American women: prevalence and risk factors.

Authors:  Tsung Mou; Oluwateniola Brown; Melissa Simon; XinQi Dong; Kimberly Kenton; C Emi Bretschneider
Journal:  Int Urogynecol J       Date:  2020-10-31       Impact factor: 2.894

7.  Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up.

Authors:  César Vargas; Alejandro García-Larrosa; Santiago Capdevila; Ainhoa Laborda
Journal:  J Endourol       Date:  2014-03-31       Impact factor: 2.942

Review 8.  LUTS and sleep disorders: emerging risk factor.

Authors:  Omer Onur Cakir; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

Review 9.  Advancing a Comprehensive Approach to the Study of Lower Urinary Tract Symptoms.

Authors:  Tamara G Bavendam; Jenna M Norton; Ziya Kirkali; Chris Mullins; John W Kusek; Robert A Star; Griffin P Rodgers
Journal:  J Urol       Date:  2016-06-21       Impact factor: 7.450

Review 10.  Diabetes and benign prostatic hyperplasia: emerging clinical connections.

Authors:  Aruna V Sarma; J Kellogg Parsons
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.